IPO registrations (S-1, F-1) · Registrants
EXAGEN INC.
- SEC CIK
- 1274737 · filings on EDGAR ↗
- Former names
- EXAGEN DIAGNOSTICS INC (2003–2017)
- Registration
- Form S-1, first filed 2014-09-19, last 2019-09-09; 2 initial registrations, 8 amendments
- Outcome
- Final prospectus filed 2019-09-20; declared effective 2019-09-18
- Industry (SIC)
- Services-Medical Laboratories 8071
- Incorporated in
- DE
- Business address
- 1261 LIBERTY WAY, Vista, CA 92081
- Ticker
- XGN (Nasdaq)
- EDGAR entity type
- operating
- Insiders and CEO pay
- EXAGEN INC. on the corporate pages
Offering terms
- Proposed price range
- $14.00–$16.00 per share (S-1/A filed 2019-09-09)
- Final price
- $14.00 per share, within the range (424B4 filed 2019-09-20, an initial public offering)
- Shares sold
- 3,600,000
- Gross proceeds
- $50,400,000 before underwriting discounts and any over-allotment option
- Listing
- Nasdaq under the symbol XGN
- Lead underwriters
- Cowen; Cantor Fitzgerald; William Blair
Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.
On this site
- Form D issuer: EXAGEN INC. EXACT (CIK (EXACT))
- Lobbying client: EXAGEN INC Fuzzy (name and state)
- SEC filer: EXAGEN INC. EXACT (CIK (EXACT))
Filings 14
| Filed | Form | What it is | Name as filed | EDGAR |
|---|---|---|---|---|
| 2014-09-19 | S-1 | S-1 (registration) | EXAGEN DIAGNOSTICS INC | 0001193125-14-347178 ↗ |
| 2014-10-09 | S-1/A | S-1/A (amendment) | EXAGEN DIAGNOSTICS INC | 0001193125-14-367938 ↗ |
| 2014-11-07 | S-1/A | S-1/A (amendment) | EXAGEN DIAGNOSTICS INC | 0001193125-14-403295 ↗ |
| 2015-02-18 | S-1/A | S-1/A (amendment) | EXAGEN DIAGNOSTICS INC | 0001193125-15-051223 ↗ |
| 2015-05-18 | S-1/A | S-1/A (amendment) | EXAGEN DIAGNOSTICS INC | 0001193125-15-190589 ↗ |
| 2015-08-12 | S-1/A | S-1/A (amendment) | EXAGEN DIAGNOSTICS INC | 0001193125-15-288148 ↗ |
| 2015-11-12 | S-1/A | S-1/A (amendment) | EXAGEN DIAGNOSTICS INC | 0001193125-15-375853 ↗ |
| 2016-02-17 | S-1/A | S-1/A (amendment) | EXAGEN DIAGNOSTICS INC | 0001193125-16-466886 ↗ |
| 2019-08-23 | S-1 | S-1 (registration) | EXAGEN INC. | 0001193125-19-228011 ↗ |
| 2019-09-09 | S-1/A | S-1/A (amendment) | EXAGEN INC. | 0001193125-19-240403 ↗ |
| 2019-09-18 | S-1MEF | S-1MEF (added securities) | EXAGEN INC. | 0001193125-19-248504 ↗ |
| 2019-09-18 | EFFECT | EFFECT (declared effective) | EXAGEN INC. | 9999999995-19-002124 ↗ |
| 2019-09-20 | 424B4 | 424B4 (final prospectus) | EXAGEN INC. | 0001193125-19-250698 ↗ |
| 2020-11-19 | EFFECT | EFFECT (declared effective) | EXAGEN INC. | 9999999995-20-003249 ↗ |
Prospectus pages read 2
| Filed | Form | Read as | Range | Price | Shares | Proceeds | Listing | Underwriters | What was found | Document |
|---|---|---|---|---|---|---|---|---|---|---|
| 2019-09-09 | S-1/A | registration statement | $14.00–$16.00 | 3,333,334 | - | Nasdaq XGN | 3 | primary document; range, shares headline, cover names 3 | document ↗ | |
| 2019-09-20 | 424B4 | final prospectus | $14.00 | 3,600,000 | $50,400,000 | Nasdaq XGN | 3 | primary document; price sentence, shares headline, proceeds table, cover names 3 | document ↗ |
Officers, directors and large holders Forms 3, 4 and 5
| Insider | Role | Title | Filings | Years | On this site |
|---|---|---|---|---|---|
| Adawi Kamal | Officer | CFO and Corporate Secretary; Chief Financial Officer | 12 | 2019–2024 | |
| Birk Brian | Director | 5 | 2019–2023 | ||
| Burrell Chet | Director | 3 | 2019–2020 | ||
| Dervieux Thierry | Officer | Chief Scientific Officer | 2 | 2019 | |
| Elliott Jeffrey Thomas | Director | 3 | 2019–2020 | ||
| H.I.G. Bio-Exagen, L.P. | TenPercentOwner | 2 | 2019 | ||
| H.I.G.-GPII, Inc. | TenPercentOwner | 2 | 2019 | ||
| Hunt Guaranty Inc. | TenPercentOwner | 8 | 2019–2021 | ||
| Hunt Holdings Limited Partnership | TenPercentOwner | 8 | 2019–2021 | ||
| HuntVest, LLC | TenPercentOwner | 8 | 2019–2021 | ||
| Hunt Woody L | TenPercentOwner | 8 | 2019–2021 | ||
| MNAYMNEH SAMI | TenPercentOwner | 2 | 2019 | ||
| NMSIC Co-Investment Fund, L.P. | TenPercentOwner | 6 | 2019–2025 | ||
| NMSIC Focused LLC | TenPercentOwner | 2 | 2019 | ||
| Nova Tina Susan | Director; Director,Officer | Executive Chairperson | 8 | 2019–2025 | |
| PALLARES EBETUEL | Director | 8 | 2019–2023 | ||
| Robertson Bruce C | Director | 5 | 2019–2026 | ||
| Rocca Fortunato R. | Director,Officer | President and CEO | 6 | 2019–2022 | |
| Sun Mountain Capital Partners LLC | TenPercentOwner | 6 | 2019–2025 | ||
| TAMER ANTHONY | TenPercentOwner | 2 | 2019 | ||
| TULLIS DICKERSON CAPITAL FOCUS III, L.P. | TenPercentOwner | 3 | 2019–2020 | ||
| TULLIS DICKERSON PARTNERS III, L.L.C. | TenPercentOwner | 3 | 2019–2020 | ||
| TULLIS GROWTH FUND II, L.P. | TenPercentOwner | 4 | 2019–2023 | ||
| Tullis Growth Fund, L.P. | TenPercentOwner | 3 | 2019–2020 | ||
| TULLIS JAMES L L | Director; Director,TenPercentOwner; TenPercentOwner | 22 | 2019–2023 | ||
| Zack Debra | Officer | Chief Medical Officer | 5 | 2020–2022 | |
| Johnson Wendy S. | Director | 6 | 2020–2023 | ||
| Hazeltine Mark | Officer | Chief Business Officer; Chief Operating Officer | 7 | 2021–2023 | |
| Stokes Frank | Director | 7 | 2021–2026 | ||
| Hooker Ana | Director | 6 | 2021–2025 | ||
| ABALLI JOHN | Director,Officer | President and CEO | 16 | 2022–2026 | |
| Kim Paul | Director | 6 | 2023–2026 | ||
| KAHN SCOTT D | Director | 4 | 2024–2026 | ||
| Black Jeffrey G. | Officer | Chief Financial Officer | 8 | 2024–2026 | |
| McKhann Chas | Director | 3 | 2026 |
Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.
Private offerings before or after (Form D)
| First filed | Issuer | Industry | Offering | Sold | Investors | Filings |
|---|---|---|---|---|---|---|
| 2019-02-01 | EXAGEN INC. | Biotechnology | $16,000,000 | $6,586,411 | 4 | 1 |
| 2017-05-18 | EXAGEN DIAGNOSTICS INC | Biotechnology | $13,179,796 | $3,749,993 | 4 | 1 |
| 2017-04-10 | EXAGEN DIAGNOSTICS INC | Biotechnology | $1,314,500 | $1,314,500 | 5 | 1 |
| 2017-03-09 | EXAGEN DIAGNOSTICS INC | Biotechnology | $1,453,000 | $1,453,000 | 4 | 1 |
| 2017-02-01 | EXAGEN DIAGNOSTICS INC | Biotechnology | $995,889 | $995,889 | 4 | 1 |
| 2016-12-19 | EXAGEN DIAGNOSTICS INC | Biotechnology | $995,889 | $995,889 | 4 | 1 |
| 2016-11-10 | EXAGEN DIAGNOSTICS INC | Biotechnology | $995,889 | $995,889 | 4 | 1 |
| 2016-10-11 | EXAGEN DIAGNOSTICS INC | Biotechnology | $995,889 | $995,889 | 4 | 1 |
| 2016-08-30 | EXAGEN DIAGNOSTICS INC | Biotechnology | $1,000,000 | $1,000,000 | 4 | 1 |
| 2016-06-24 | EXAGEN DIAGNOSTICS INC | Biotechnology | $2,100,000 | $2,100,000 | 6 | 1 |
| 2016-01-26 | EXAGEN DIAGNOSTICS INC | Biotechnology | $30,852,618 | $16,817,541 | 13 | 1 |
| 2015-10-21 | EXAGEN DIAGNOSTICS INC | Biotechnology | $4,500,000 | $2,999,766 | 4 | 1 |
| 2015-07-06 | EXAGEN DIAGNOSTICS INC | Biotechnology | $3,000,000 | $3,000,000 | 3 | 1 |
| 2015-04-01 | EXAGEN DIAGNOSTICS INC | Biotechnology | $4,547,811 | $1,818,767 | 8 | 1 |
| 2014-07-21 | EXAGEN DIAGNOSTICS INC | Biotechnology | $3,950,000 | $3,950,000 | 12 | 1 |
Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.
Also on this site Fuzzy
| Record | Name as filed | Where | Dataset | Matched by |
|---|---|---|---|---|
| Form D issuer | EXAGEN INC. | CA | Form D private offerings | CIK (EXACT) |
| SEC filer | EXAGEN INC. | SEC filers (EDGAR) | CIK (EXACT) | |
| Lobbying client | EXAGEN INC | Federal lobbying (LDA) | name and state |
Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.
Others with the same interests
SIC industry Services-Medical Laboratories, CA first:
- INSIGHT HEALTH SERVICES CORP CA
- CLARIENT, INC CA
- BIOCEPT INC CA
- SPECIALTY LABORATORIES INC CA
- GENOMIC HEALTH INC CA
- PERLEGEN SCIENCES, INC. CA
- GENOPTIX INC CA
- INSIGHT HEALTH SERVICES HOLDINGS CORP CA
- CareDx, Inc. CA
- CARDIODX INC CA
In other datasets, the same topic (Health) in CA:
- Nonprofit: 24 HOUR CANCER DANCE-A-THON (Nonprofits (IRS Form 990))
Interests: Services-Medical Laboratories · Health